EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H22FN5O3.C6H6O3S |
| Net Charge | 0 |
| Average Mass | 581.626 |
| Monoisotopic Mass | 581.17443 |
| SMILES | C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1 |
| InChI | InChI=1S/C22H22FN5O3.C6H6O3S/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2;7-10(8,9)6-4-2-1-3-5-6/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28);1-5H,(H,7,8,9) |
| InChIKey | ABSXPNGWJFAPRT-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Applications: | antirheumatic drug A drug used to treat rheumatoid arthritis. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| spebrutinib besylate (CHEBI:755283) has role antineoplastic agent (CHEBI:35610) |
| spebrutinib besylate (CHEBI:755283) has role antirheumatic drug (CHEBI:35842) |
| spebrutinib besylate (CHEBI:755283) is a organosulfur compound (CHEBI:33261) |
| spebrutinib besylate (CHEBI:755283) is a sulfonic acid derivative (CHEBI:33552) |
| Synonyms | Source |
|---|---|
| AVL-292 | ChEMBL |
| AVL-292 BESYLATE | ChEMBL |
| CC-292 | ChEMBL |
| CC-292 BESYLATE | ChEMBL |
| Spebrutinib | ChEMBL |
| Spebrutinib besilate | ChEMBL |